Nokia
Real-time clinical networks at scale
Issy-les-Moulineaux, France
Nokia acquired French digital health company Withings in 2016 for $192 million, rebranding its products. After struggling, the digital health business was sold back to Withings' co-founder in 2018. Nokia now focuses on providing intelligent infrastructure and digital technologies to healthcare organizations, leveraging technologies like 5G-Advanced and 6G.
How We Help
Problem Statement
Lack of accurate and consistent patient-generated health data for both consumer self-monitoring and remote patient tracking by physicians.
Core Technology
5G-Advanced; 6G; intelligent infrastructure; private network solutions; AI for diagnostics
Key Differentiators
Accurate collection of patient-generated health data, remote patient tracking capabilities, comprehensive product portfolio, and dedicated B2B solutions for healthcare providers and researchers.
Clinical Focus
Obesity, diabetes, hypertension, chronic heart failure, elderly care, and support for decentralized clinical trials.
Target Customers
Consumers, healthcare providers, and researchers.
Product Stage
Mature
Company Info
- Business Model
- B2C, B2B, Subscription
- Founded
- 2008
- Total Funding
- 93,800,000
- Website
- www.withings.com
Categories
Technologies
Clinical & IP
Clinical Validation
Devices are utilized for real-world data collection in decentralized clinical trials.
MedStartr Index Score
?What do you think of Nokia?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.